© BusinessWire
16.12.2025
STOK
LISTED
NASDAQ
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effe...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
SLDB
LISTED
XNMS
Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services
News Preview
CHARLESTOWN, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today shared that the U.S. Department of Health and Human Services (HHS) officially added Duchenne muscular dystrophy (Duchen...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
MAIA
LISTED
XASE
MAIA Biotechnology Announces $1.51 Million Private Placement
News Preview
CHICAGO, IL, Dec. 16, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,233,488 shares of common st...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
16.12.2025
CLOV
LISTED
NASDAQ
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
News Preview
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference on Thursday, January
15, 2026, at 11:15 a.m. ET....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
16.12.2025
STRO
LISTED
NASDAQ
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that on December 15, 2025, the Compensation Committee of Sutro’s Board of Directors granted stock o...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
BBOT
LISTED
NASDAQ
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BBOT today announced that members of its leadership team will participate in a presentation at the 44th Annual J.P. Morgan Healthcare Conference....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
CAPR
LISTED
NASDAQ
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
News Preview
– Webinar to be held Wednesday, December 17, 2025, at 1:00 p.m. ET –...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
DBV
LISTED
EURONEXT
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
News Preview
Châtillon, France, December 16, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
FBLG
LISTED
NASDAQ
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
HOUSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
IRD
LISTED
NASDAQ
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
VITR
LISTED
STO
Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment
News Preview
GOTHENBURG, Sweden, Dec. 16, 2025 /PRNewswire/ -- Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services business. The program is targeting annualised savings of SEK 65 million, expected to have a positive impact in the first half of 2026, and to reach ful...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
STAA
LISTED
NASDAQ
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today released the following letter to STAAR shareholders in response to the updated reports of Institutional Shareholder Services In...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
16.12.2025
AVBP
LISTED
NASDAQ
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
News Preview
Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Dec. 16, 2025 /CNW/ -- USANewsGroup.com News Commentary – Gastrointestinal cancers that once resisted checkpoint inhibitors are finally responding to novel combination strategies[1], with the FDA fast-tracking multiple targeted therapies designed to transform immunologically cold tumors int...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
AVBP
LISTED
NASDAQ
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
News Preview
Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Dec. 16, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Gastrointestinal cancers that once resisted checkpoint inhibitors are finally responding to novel combination strategies[1], with the FDA fast-tracking multiple targeted therapies designed to transform immunologically cold tum...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
LCTX
LISTED
TLV
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
News Preview
Issued on behalf of Avant Technologies Inc.Equity Insider News CommentaryVANCOUVER, BC, Dec. 16, 2025 /CNW/ -- The cell therapy manufacturing sector reached a pivotal inflection point in late 2025, with contract development and manufacturing organizations capturing 67.5% market share as the industry transitions from boutique R&D operations to...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
LCTX
LISTED
TLV
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
News Preview
Issued on behalf of Avant Technologies Inc.Equity Insider News CommentaryVANCOUVER, BC, Dec. 16, 2025 /PRNewswire/ -- The cell therapy manufacturing sector reached a pivotal inflection point in late 2025, with contract development and manufacturing organizations capturing 67.5% market share as the industry transitions from boutique R&D operati...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.12.2025
HBMN
LISTED
SIX
Key Figures
15.12.2025
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.12.2025
16.12.2025 / 17:45 CET/CEST
in CHF
Performance in %
15.12.2025
MTD
FYTD
CYTD
NAV
281.27
4.5
18.2
......
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
ALVO
LISTED
ICE
Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance
News Preview
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDIT...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
EAPI
LISTED
EURONEXT
Market update
News Preview
Paris – December 16, 2025 - EUROAPI announced today that its main shareholders, Sanofi and EPIC Bpifrance, have agreed to extend further the duration of their lock-up until December 18, 2026, subject to customary exceptions. This extension strengthens the stability of EUROAPI’s shareholding structure throughout the execution of its FOCUS-27 plan....
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
LLY
LISTED
NYSE
Lilly to participate in J.P. Morgan Healthcare Conference
News Preview
INDIANAPOLIS, Dec. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025. David A. Ricks, Lilly chair and CEO, will take part in a fireside chat on Tuesday Jan. 13 at 5:15 p.m., Eastern time.A live audio webcast will be available on the "Webcasts & Pre...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
BAYN
LISTED
XETR
Introducing Sivanto Energy: Enhanced Flea Beetle Control
News Preview
Bayer Crop Science Canada is excited to announce the launch of Sivanto® Energy, a groundbreaking foliar insecticide designed to deliver swift, reliable pest control with extended protection. Formulated to deliver two highly effective modes of action, Sivanto Energy combines the strengths of deltamethrin and flupyradifurone to provide unparalleled...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
STAA
LISTED
NASDAQ
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported that independent industry analysts have recognized the value provided to STAAR stockholders by the Company’s amended merger agreement with Alcon (SIX/NYSE: ALC) and the merits...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.12.2025
MED
LISTED
XETR
Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025
News Preview
Offenburg, 16. Dezember 2025. Der Vorstandsvorsitzende der MEDICLIN Aktiengesellschaft, Dr. Joachim Ramming, wird sein Mandat zum Ende des Geschäftsjahres 2025 am 31. Dezember 2025 im besten gegenseitigen Einvernehmen auf eigenen Wunsch niederlegen. Dr. Ramming ist seit Juni 2015 für den Asklepios-Konzern tätig und gehört dem Vorstand der MEDICLIN ......
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
IBRX
LISTED
NASDAQ
ANKTIVA® with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival Not Yet Reached in BCG-Unresponsive High-Grade Papillary-Only Non-Muscle Invasive Bladder Cancer
News Preview
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy at 12 and 36 months, including disease-free survival (DFS), disease-specific survival (DSS), long-term progression-free survival (PFS), and high cys...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
HLN
LISTED
LSE
Glasgow Caledonian University to Lead £2.6m UK Doctoral Training Programme to Tackle Global Oral Health Challenges
News Preview
Glasgow Caledonian University has secured £2.6 million to lead a major new UK-wide doctoral training programme to spearhead research into oral health and dental disease prevention.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216404233/en/
Funded by the Biotechnology and Biological...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
A
LISTED
NYSE
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will present at the 44th Annual J.P. Morgan Healthcare Conference at 9 to 9:40 a.m. PST on Tuesday, Jan. 13, 2026.
A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.
About Agilent Te...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
CLTX
LISTED
NASDAQ
Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market
News Preview
New cash portion of offering includes >20% participation from Directors, Officers and Executive Management New cash portion of offering includes >20% participation from Directors, Officers and Executive Management...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
CANF
LISTED
XASE
Can-Fite Provides Update on Clinical and Financial Status
News Preview
RAMAT GAN, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced an update on its clinical development activities and financial status....
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
TAK
LISTED
NYSE
British Columbia reimburses FRUZAQLA™ (fruquintinib capsules) for the treatment of metastatic colorectal cancer (mCRC)
News Preview
TORONTO, Dec. 16, 2025 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by BC Cancer as a treatment option for adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with, or are not considered candidates, for available standard...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
HOLX
LISTED
NASDAQ
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
News Preview
Hologic, Inc. (Nasdaq: HOLX), a leading medical technology company dedicated to improving women’s health, today announced new data that highlights how the company’s advanced AI-powered mammography solution can aid in detecting more breast cancers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
HUM
LISTED
NYSE
Humana Announces Insurance Leadership Transition
News Preview
Humana Inc. (NYSE: HUM) today announced that George Renaudin, Insurance Segment President and member of Humana’s Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana’s Medicare Advantage and Medicaid programs, h...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
SIA
LISTED
TSX
Sienna Completes Acquisition in Waterloo, Ontario
News Preview
This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus supplement dated November 14, 2025 to its short form base shelf prospectus dated November 29, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
ZYXI
LISTED
NASDAQ
Zynex Financial Restructuring Puts Company on Path to Long-Term Success
News Preview
ENGLEWOOD, Colo., Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation today announced it has voluntarily entered into a Chapter 11 court-supervised financial restructuring with the support o...
Themefolio
Profiler
Peergroup
© Newsfile
16.12.2025
FEED
LISTED
NASDAQ
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
News Preview
Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantagesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully impl...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
NTRA
LISTED
NASDAQ
I-SPY 2 Publication in Nature Communications Shows Signatera™ Can Predict Treatment Response and Recurrence Risk in Early-Stage Breast Cancer
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, together with Quantum Leap Healthcare Collaborative, today announced the publication of new findings from the I-SPY 2 trial in Nature Communications.
The study examined how Signatera can refine risk assessment in patients with early-stage breast cancer whose tum...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
DCGO
LISTED
NASDAQ
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the DocGo Securities Litigation
News Preview
The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the DocGo Securities Litigation:
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
GENESEE COUNTY EMPLOYEES’ RETIREMENT
SYSTEM, Individually and on Behalf of All Others
Similarly Situated,
Civil Action No. 1:23-cv-09476-KPF
CLASS ACTION...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
RVTY
LISTED
NYSE
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery
News Preview
Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica™ Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica offering will enable AI-augmented molecular and materials design, and brings together advanced in‑silico generation, predictive modeling, and experimen...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.12.2025
GALE
LISTED
SIX
Galenica baut Online-Angebot weiter aus und übernimmt Mehrheit an Puravita
News Preview
Galenica AG
/ Schlagwort(e): Firmenübernahme
Galenica baut Online-Angebot weiter aus und übernimmt Mehrheit an Puravita 16.12.2025 / 13:55 CET/CEST
Medienmitteilung
Galenica erhöht ihre Beteiligung an Puravita auf 80 Prozent und baut ihre digitale Präsenz weiter aus.
Damit erweitert Galenica das Online-Angebot im Drogerie- u......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.12.2025
GALE
LISTED
SIX
Galenica further expands online offering and acquires majority stake in Puravita
News Preview
Galenica AG
/ Key word(s): Takeover
Galenica further expands online offering and acquires majority stake in Puravita 16.12.2025 / 13:55 CET/CEST
Press release
Galenica increases its investment in Puravita to 80% and further expands its digital presence.
In doing so, Galenica is expanding its online offering in the drugstore ......
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
SLXN
LISTED
NASDAQ
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
News Preview
Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
NKTR
LISTED
NASDAQ
REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
News Preview
Achieved target product profile on the primary endpoint, with a mean percent reduction in SALT score at 36 weeks of 28.2% in the 24 µg/kg arm versus 11.2% in placebo Mean percent reduction in SALT scores at 36 weeks was 30% for both treatment arms versus 6% for placebo, achieving statistical significance (p<0.05) when excluding four patients th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
ZBH
LISTED
NYSE
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
News Preview
OneStep's Clinically Validated Mobility Intelligence Technology to Integrate into Zimmer Biomet's mymobility® Care Management Platform to Further Enhance Recovery MonitoringWARSAW, Ind., Dec. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and OneStep, the FDA-listed digital fall preve...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
AIAI
LISTED
CSE
NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression
News Preview
TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced alongside the Centre for Addiction and Mental...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
ITGR
LISTED
NYSE
Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ITGR
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Integer Holdings Corporation (“Integer” or “the Company”) (NYSE: ITGR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of ITGR duri...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
CLRB
LISTED
NASDAQ
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
News Preview
Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid Tumors Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid Tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
JUSH
LISTED
CSE
Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement
News Preview
BOCA RATON, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announces that in order to assist the Company in managing near-term working capital requirements, the Company and Jim Cacioppo, the Company’s Chairman and Chief Exec...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
GKOS
LISTED
NYSE
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 4:30 p....
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
PODD
LISTED
NASDAQ
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
News Preview
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 11:15 a.m. (Pacific Time).
The live webcast and replay of the presentation...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on a report published by Institutional Shareholder Services Inc. (“ISS”), an independent proxy advisory firm, which reiterates that firm’s significant concerns regarding the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by A...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
PFE
LISTED
NYSE
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
News Preview
Pfizer Inc. (NYSE:PFE) today provided its full-year 2026 guidance(2) while revising its November 4, 2025 full-year 2025 Revenue guidance(2) and reaffirming all other components of full-year 2025 financial guidance(2). The accompanying presentation can be found at www.pfizer.com/investors.
FULL-YEAR 2026 REVENUE GUIDANCE(2)
Pfizer anticipates ful...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
RGEN
LISTED
NASDAQ
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
News Preview
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new high-performance chromatography resins: AVIPure® HiPer™ AAV9 and AVIPure® HiPer™ AAV8 affinity resins, along with HiPer™ QA anion exchange resin, expa...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
PVLA
LISTED
NASDAQ
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
News Preview
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
RPRX
LISTED
NASDAQ
Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million
News Preview
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib from an undisclosed third party for up to $315 million....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
MPLT
LISTED
NASDAQ
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
News Preview
SAN FRANCISCO and BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SandboxAQ and MapLight Therapeutics, Inc. (Nasdaq: MPLT) announced today that the companies have entered into a strategic collaboration to discover and develop potential first-in-class therapies targeting a novel G protein-coupled receptor (GPCR) for the treatment of central nervous syst...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2025
TNXP
LISTED
NASDAQ
Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University
News Preview
Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic pain...
Themefolio
Profiler
Peergroup
© Newsfile
16.12.2025
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces the Signing of a Secured Real Estate Location for Georgetown, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - December 16, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, is pleased to announce that its Heal Wellness brand ("Heal") has signed a real estate location for Georgetown, Ontario. This milestone further advan...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2025
OGI
LISTED
NASDAQ
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results
News Preview
Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (“Q4 Fiscal 2025” or "Fiscal 2025"). All financial information in this press release is expressed in Can...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.12.2025
MDCE
LISTED
OTC
Medical Care Technologies (OTC Pink:MDCE) Deploys AI to Identify Historic Memorabilia Acquisitions Strengthening Long-Term Financial Stability
News Preview
AI-Identified Memorabilia Acquired This Weekend Expected to Support Long-Term Funding for Technology Development MESA, ARIZONA / ACCESS Newswire / December 16, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is thrilled to announce the powerful collaboration between its subsidiaries, Real Game Used (RGU) and Infinite Auctions. Utilizing RGU's...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
